Eli Lilly's Internal Probe Clears Its COVID-19 Drug Plant; Memo Says Company Did Not Make False Statements: Reuters

  • Eli Lilly and Co LLY revealed last month that the U.S. Department of Justice (DOJ) issued a subpoena into its manufacturing facility in Branchburg, New Jersey, but the company has already finished its independent investigation and concluded the company didn’t make false statements to the FDA, Reuters reports.
  • In the internal memo, the company denied allegations that it made any false statements to the FDA. Eli Lilly, however, didn’t cover all of the employee complaints in the note.
  • Lilly based its internal probe on interviews with more than 100 people.
  • While Lilly may have cleared itself in an internal probe, it remains to be seen how the DOJ will proceed.
  • As Reuters notes, if federal prosecutors determine the company’s probe was thorough, they may not press the issue much further.
  • But if they find weaknesses in the internal investigation, they could take a stricter approach.
  • Price Action: LLY shares are down 4.6% at $222.9 during the market session on the last check Friday.

Posted In: BriefsCOVID-19 VaccineReutersBiotechNewsHealth CareFDALegalGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.